Last updated 2026-07-26
- Raised $21M Series C led by European Innovation Council, Apr 2026
- Raised $7M Series B, Sep 2020
- Raised $2M Series A led by Paul Merage, Dec 2019
Total raised
$30.0M
Last: Undisclosed Round 2026-05
Stage
Series C
Founded
2014
Headcount
20
HQ
Yokneam Illit, Israel
Sector
Health Tech & Life Sciences
About
Butterfly Medical is an Israeli medical device company that develops an innovative, implantable device for the treatment of Benign Prostatic Hyperplasia (BPH). The Butterfly Medical device is a new generation of minimally invasive BPH treatment that does not require cutting or removing tissue. It is designed to restore natural urinary flow and provide significant, long-term relief from BPH symptoms. The device has received CE Mark approval for use in Europe and is currently an investigational device in the USA, limited by federal law to investigational use.
Funding history · 3 rounds · $30.0M total
2026-04
C Round
$21.0M
★ European Innovation Council
2020-09
B Round
$7.0M
Mori Arkin
2019-12
A Round
$2.0M
★ Paul MerageMori ArkinDan SuesskindKamran SiminouAlon MedTech Ventures
Headcount over time
From 3 (2018-08) to 20 (2026-07) · +17 (+567%) · 30 points · source: Finder history + radar grounding
Q&A
- What is Butterfly Medical's primary focus?
- Butterfly Medical is an Israeli medical device company focused on developing an innovative, implantable device for the treatment of Benign Prostatic Hyperplasia (BPH).
- When was Butterfly Medical founded?
- Butterfly Medical was founded in 2014.
- What is the current employee count for Butterfly Medical?
- Butterfly Medical has 11-50 employees.
- What was Butterfly Medical's most recent funding round?
- In May 2026, Butterfly Medical secured a $21 million Series C funding round. Lead investors included European Innovation Council and Junson Capital.
- What is the total amount of funding Butterfly Medical has raised to date?
- Butterfly Medical has raised a total of $32.7 million USD.
- What is the regulatory status of Butterfly Medical's device?
- The Butterfly Medical device has received CE Mark approval for use in Europe and is currently an investigational device in the USA, limited by federal law to investigational use.
- Did Butterfly Medical receive any grants recently?
- In September 2023, Butterfly Medical received a grant of $2.5 million from the European Innovation Council.
- What is the product stage of Butterfly Medical's device?
- The Butterfly Medical device is currently in the clinical trial stage.
Team · 2
Yehuda Bachar
Founder · Co-Founder
Adrian Paz
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcarePatientsProvidersConsumersDemographics & FamilySeniors
Business model
B2B2C
Highlights
1 PatentsVerified
Tags
patientsdoctorsmedical-devicesminimally-invasivenon-surgicaltreatmentsclinicsmedical-productsseniorsurology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | butterfly-medical.com |
|---|---|
| linkedin.com/company/17909086 | |
| facebook.com/Butterfly-Medical-1050294178416141 |
Identifiers & details
| Legal name | Butterfly Medical Ltd. |
|---|---|
| Founded | 2014 |
| Employees (exact) | 20 |
Radar intelligence
Patents
| EPO | 8 |
|---|
Web history (Wayback)
| Domain | butterfly-medical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515136331 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-09-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 1 — shares_capital (1) |
| Registered address | התנופה 3 יקנעם עילית |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-03 | העברת מניות |